Tutorials
United Therapeutics Corp logo

United Therapeutics Corp

€ 212.40 (-0.93%) Aug 12
P/E:
16.43
P/B:
2.29
Market Cap:
€ 9.57B ($ 9.83B)
Enterprise V:
€ 8.16B ($ 8.38B)
Volume:
-
Avg Vol (2M):
12.00
Also Trade In:
Volume:
-
Market Cap €:
9.57B
Market Cap $:
9.83B
PE Ratio:
16.43
Avg Vol (2-Month):
12.00
Enterprise Value €:
8.16B
Enterprise Value $:
8.38B
PB Ratio:
2.29
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

United Therapeutics Corp
NAICS : 325412 SIC : 2834
1040 Spring Street, Silver Spring, MD, USA, 20910
Description
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Financials (Next Earnings Date:2022-11-03 Est.)

FRA:UTH's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 1,606.54
EPS (TTM) (€) 11.834
Beta 0.05
Volatility % 42.58
14-Day RSI 40.84
14-Day ATR (€) 3.418516
20-Day SMA (€) 221.245
12-1 Month Momentum % 39.02
52-Week Range (€) 146 - 241
Shares Outstanding (Mil) 45.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

United Therapeutics Corp Filings

Document Form Filing Date
No Filing Data